Investor Steve Grasso sees an opportunity in MaxLinear after a sharp stock sell-off, citing strong earnings and booming AI data center demand.
West Pharma earnings show it’s more than a GLP-1 play. Why we see more upside
Since CNBC highlighted the stock’s attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.
How Todd Gordon is trading Meta as the stock market rotates out of growth and into value names
The Street is again heavily questioning Meta’s spending, says Todd Gordon.
GM is shifting gears to the Nasdaq, trying to draft behind Walmart’s lead
GM plans to move its stock listing to Nasdaq on Nov. 17, opening the door to possible Nasdaq-100 inclusion and an improved valuation.
There’s a cybersecurity stock on Josh Brown’s list that’s pulling back. How he’s trading it
Last night, security play Fortinet (FTNT) disappointed the Street, and its peer group of stocks is paying for it.
JPMorgan says Palantir to rally more than 30%, names it a favorite stock
Palantir Technologies is likely to rally thanks to a focus on sovereign AI and increased usage by large business and government clients, the bank says.
Microsoft’s latest earnings beat the Street. Here’s what analysts are saying
Microsoft topped earnings expectations for the three-month period ended Sept. 30. Analysts say the stock still has more room to run amid an AI boom.
Why traders are rushing for the exits on Alphabet
Traders are rushing for the exits on Alphabet to try to preserve any profit they have left in the struggling technology bellwether, explains Steve Grasso.
Here are Thursday’s biggest analyst calls: Nvidia, Anthropic, Apple, Tesla, Chevron, Microsoft, Alphabet & more
Here are Thursdays’ biggest calls on Wall Street.
Alphabet’s third-quarter results missed expectations. They led one analyst to downgrade the stock
Alphabet sold off following a lackluster third-quarter financial report, raising questions on Wall Street about what’s next for the tech giant as the artificial intelligence revolution continues.